Global Fully MagLev Left Ventricular Assist Device (LVAD) Market Growth 2024-2030

Global Fully MagLev Left Ventricular Assist Device (LVAD) Market Growth 2024-2030

A left ventricular assist device (LVAD) is a medical device helps heart pump better when patients have heart failure. Some people use this while waiting for a heart transplant. The MagLev (Magnetic Levitation) ventricular assist device (VAD), also known as a magnetic levitation artificial heart, is an advanced medical device used to treat severe heart failure. The magnetic levitation VAD belongs to the third generation of centrifugal pump type VAD, which is divided into fully magnetic levitation and magnetic-fluid hybrid levitation bearing technology. Depending on their location, fully magnetic levitation VADs can generally be divided into left ventricular assist devices (LVADs), right ventricular assist devices (RVADs), and biventricular assist devices (BiVADs).

The global Fully MagLev Left Ventricular Assist Device (LVAD) market size is projected to grow from US$ 1064 million in 2024 to US$ 2212 million in 2030; it is expected to grow at a CAGR of 13.0% from 2024 to 2030.

LP Information, Inc. (LPI) ' newest research report, the “Fully MagLev Left Ventricular Assist Device (LVAD) Industry Forecast” looks at past sales and reviews total world Fully MagLev Left Ventricular Assist Device (LVAD) sales in 2023, providing a comprehensive analysis by region and market sector of projected Fully MagLev Left Ventricular Assist Device (LVAD) sales for 2024 through 2030. With Fully MagLev Left Ventricular Assist Device (LVAD) sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Fully MagLev Left Ventricular Assist Device (LVAD) industry.

This Insight Report provides a comprehensive analysis of the global Fully MagLev Left Ventricular Assist Device (LVAD) landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Fully MagLev Left Ventricular Assist Device (LVAD) portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Fully MagLev Left Ventricular Assist Device (LVAD) market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Fully MagLev Left Ventricular Assist Device (LVAD) and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Fully MagLev Left Ventricular Assist Device (LVAD).

Currently, the global fully magnetic left levitation ventricular assist device (LVAD) market is monopolized by Abbott's HeartMate 3, which has now become the most commonly used left ventricular assist device (LVAD) in the world, with a market share of over 80%.

From the perspective of the global LVAD device market, the main manufacturer in the United States is Abbott, and full magnetic levitation products have become the absolute mainstream. Competition in Europe is more intense, with more products approved earlier, but they are mainly used the second-generation technology (axial pump). The main player is Berlin heart CmbH.

This report presents a comprehensive overview, market shares, and growth opportunities of Fully MagLev Left Ventricular Assist Device (LVAD) market by product type, application, key manufacturers and key regions and countries.

Segmentation by Type:
Implantable VAD
External VAD

Segmentation by Application:
Bridge-to-transplant (BTT)
Destination Therapy (DT)
Others

This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analysing the company's coverage, product portfolio, its market penetration.
Abbott
Suzhou Tongxin Medical Devices
Shenzhen Core Medical Technology

Key Questions Addressed in this Report

What is the 10-year outlook for the global Fully MagLev Left Ventricular Assist Device (LVAD) market?

What factors are driving Fully MagLev Left Ventricular Assist Device (LVAD) market growth, globally and by region?

Which technologies are poised for the fastest growth by market and region?

How do Fully MagLev Left Ventricular Assist Device (LVAD) market opportunities vary by end market size?

How does Fully MagLev Left Ventricular Assist Device (LVAD) break out by Type, by Application?



Please note: The report will take approximately 2 business days to prepare and deliver.